Table:
begin	end	state
1	20	cytoplasmic
21	42	transmembrane
43	47	non-cytoplasmic
48	69	transmembrane
70	87	cytoplasmic
88	109	transmembrane
110	128	non-cytoplasmic
129	151	transmembrane
152	162	cytoplasmic
163	184	transmembrane
185	203	non-cytoplasmic
204	225	transmembrane
226	245	cytoplasmic
246	267	transmembrane
268	291	non-cytoplasmic
292	317	transmembrane
318	336	cytoplasmic
337	359	transmembrane
360	364	non-cytoplasmic
365	387	transmembrane
388	407	cytoplasmic
408	430	transmembrane
431	436	non-cytoplasmic
437	455	transmembrane
456	470	cytoplasmic

Input:
>AO353_24825 FitnessBrowser__pseudo3_N2E3:AO353_24825
MSESIERKGIHLTRALKSRHIFMLSLGGVIGTGLFMGSGVTINQGGPVGAILAYLIAGFL
MYLVMVCLGELSVQMPVSGSFQTHATKFIGPATGFMIGWVYWMSWASTVGLEFTAAGMLM
VRWFPTVPIWYWSALFVVVLFGLNALATRAFGEAEYWFSGIKVAAILGFIVVGVLVIFGA
IPLTSGAPAPMMSNLIGDSLFPNGLPAVFAVMMTVVYAFQGCEIMGVAAGETDQPEKSIP
RAVRNVVFRVLIFYVLAIVVLSAIVPWQQAGLMESPFVQVFDMVGIPYAADLMNFVILTA
ILSVGNSGLYASTRILWAMSKTGMAPKSLSPLSKRGVPLRALSITLCFALVSLMTSFIAA
DTLFMVLMAVSGMSGTVTWIVIALAQYKFRRAYIRDGGKLSDLKYRAPWFPLLPILCIAL
CCSLFVFLAMDETQRPSLYWGFGFMALCYGAYFLIQRKRQAVLAPSLPTV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server